Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population
NCT ID: NCT02214043
Last Updated: 2018-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2012-01-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China
NCT01717092
Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China
NCT03185377
Pulmonary Embolism Prognosis Model
NCT04411888
Pulmonary Embolism: Mechanism and Therapeutic Innovation
NCT05360992
An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
NCT05481242
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 2
No interventions assigned to this group
group 1
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* chronic obstructive pulmonary disease;
* a prior documented episode of PE or DVT
* renal dysfunction;
* a life expectancy of less than 6 months
15 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Pulmonary Vascular Disease Research Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhihong Liu, Doctor
Role: STUDY_CHAIR
Chinese pulmonary vascular disease organization group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center of pumonary vascular diseases
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APEINCP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.